Evidence map›Paper›PMID 36274166›Full record

Trial reportTrials2022

The use of 3D ceramic block graft compared with autogenous block graft for rehabilitation of the atrophic maxilla: a randomized controlled clinical trial.

Carolina Mendonça de Almeida Malzoni, Victor Gonçalves, Juliana Possari, Elcio Marcantonio Junior

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carolina Mendonça de Almeida MalzoniDepartment of Diagnosis and Surgery, School of Dentistry, São Paulo State University - UNESP, Araraquara, SP, Brazil. ca.malzoni@gmail.com.
Victor GonçalvesDepartment of Diagnosis and Surgery, School of Dentistry, São Paulo State University - UNESP, Araraquara, SP, Brazil.
Juliana PossariDepartment of Diagnosis and Surgery, School of Dentistry, São Paulo State University - UNESP, Araraquara, SP, Brazil.
Elcio Marcantonio JuniorDepartment of Diagnosis and Surgery, School of Dentistry, São Paulo State University - UNESP, Araraquara, SP, Brazil.
Universidade Estadual Paulista (Unesp) · BR

Funding

M3 Health Ind. Com. de Prod. Méd., Odont. e Correlatos SA 006
6 · The paper itself

Abstract

backgroundDental implant placement may require a bone graft for vertical and horizontal alveolar ridge augmentation. Due to its osteoconduction, osteoinductive, and osteogenesis, autogenous bone graft characteristics are considered the standard gold treatment. However, autografts can promote postoperative morbidity and implicate difficulties concerning the graft adaptation to the recipient's bone since it can eventually avoid gaps. To overcome these issues, this trial will compare the performance of Plenum

methodsThis is a split-mouth randomized clinical study designed to evaluate the performance of personalized (patient-specific) bioceramic bone grafts (Plenum DISCUSSION: The fabrication of medical devices by additive manufacturing presents advantages over conventional manufacturing processes, mostly related to the precision of geometry and anatomy. Additionally, the osteoconductive proprieties of β-tricalcium phosphate enable this synthetic bone substitute as an alternative solution over autogenous graft for bone defect reconstruction. Thus, patient-specific bone grafts can potentially improve patient satisfaction, reducing the need for autogenous bone grafts, consequently avoiding implications related to this type of treatment, such as patient morbidity.

trial registrationThis study is registered in REBEC (Registro Brasileiro de Ensaios Clínicos): RBR-76wmm3q; UTN: U1111-1272-7773. Registration date: 14 September 2021.

Indexed as

Bone SubstitutesDental ImplantsAtrophyAutograftsBone TransplantationCalcium PhosphatesCeramicsDental Implantation, EndosseousGoldHumansMaxillabeta-tricalcium phosphateBone SubstitutesCalcium PhosphatesDental ImplantsGold3D-printed bone graftAtrophic maxillaPatient-specific bone graftSynthetic bone substituteβ-tricalcium phosphate

Identifiers

PMID36274166
PMCPMC9590225
OpenAlexW4307106837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.